CBAY   $32.48  0.03% Market Open

Cymabay Therapeutics Inc
Total Cash 394.26M
totalCashPerShare 3.437
EBITDA -101.00M
Total Debt 114.49M
quickRatio 10.701
currentRatio 10.96
Total Revenue 31.07M
debtToEquity 39.176
Revenue/Share 0.293
ROA -0.22045
ROE -0.64169997
grossProfits
freeCashflow -54.82M
operatingCashflow -72.53M
earningsGrowth
revenueGrowth
grossMargins -1.6003
ebitdaMargins 0.0
operatingMargins -745.579
profitMargins 0.0
enterpriseValue 3.45B
forwardPE -30.933334
floatShares 96.64M
sharesOutstanding 114.78M
sharesShort 5.85M
sharesShortPriorMonth 9.30M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.03%
Short Ratio help_outline 0.84%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 2.567
Price To Book help_outline 12.65
earningsQuarterlyGrowth
netIncomeToCommon -105.37M
trailingEps -0.99%
forwardEps -1.05%
enterpriseToEbitda -34.12
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.3 1Q 2024
institutionsCount 275
lastUpdated April 1, 2024, 11:56 a.m.